Viyash Scientific has secured Italian FDI approval for its step-down subsidiary Alivira Animal Health to acquire BioForLife Italia. The transaction is now expected to close within two months, pending final customary formalities.
Viyash Scientific allotted 6,12,773 new equity shares under ESOPs, at Rs. 86 and Rs. 101 per share. This action increased the total paid-up equity capital to ~Rs. 88.10 Cr, slightly diluting existing shareholders.
Viyash Scientific Limited hosted an earnings conference call to discuss the financial results for the first quarter of FY'27. The company reported a strong quarter with revenue from operations at Rs. 946 Cr, up 20% YoY. EBITDA surged 59% YoY to Rs. 205 Cr, with margins expanding to 21.6%. Profit...
Viyash Scientific Limited has announced the audio recording of its earnings call for the quarter ended June 30, 2026, is now available on the company's website. The call discussed the unaudited financial results.
Viyash Scientific Limited has informed the Exchange about Copy of Newspaper Publication for Q1 FY 27 Financial Results.
